Trial intelligence / Profile preview

Donor Simvastatin Treatment in Organ Transplantation

NCT01160978Phase 3Completed

Sponsor
Helsinki University Hospital
Start
Jun 2010
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of simvastatin in ischemia-reperfusion injury (IRI), sponsored by Helsinki University Hospital. Started Jun 2010; status: completed.

02

Drugs

simvastatin
03

Conditions

ischemia-reperfusion injury (IRI)

Beyond the preview

Go deeper on NCT01160978.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01160978.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call